Results: 2

1.
FIG. 1

FIG. 1. From: Effects of Alum Adjuvant or a Booster Dose on Immunogenicity during Clinical Trials of Group B Streptococcal Type III Conjugate Vaccines.

Adsorption of alum to GBS III-TT vaccine. Inhibition of GBS type III-specific antibody binding to type III CPS-coated microtiter plates by 12.5 μg of III-TT lot 1-1-95 incubated with (●) or without (○) alum. These data were obtained after 1 day of adsorption and are representative of adsorption measured at each time point tested.

L. C. Paoletti, et al. Infect Immun. 2001 November;69(11):6696-6701.
2.
FIG. 2

FIG. 2. From: Effects of Alum Adjuvant or a Booster Dose on Immunogenicity during Clinical Trials of Group B Streptococcal Type III Conjugate Vaccines.

Immune response in healthy adults to two doses of GBS III-TT conjugate vaccine. The data presented are the percentages of peak type III CPS-specific GMCs elicited after the first dose in 28 of 36 subjects with prevaccination concentrations of type III CPS-specific IgG of >0.05 μg/ml (□) and in 8 subjects with prevaccination concentrations of <0.05 μg/ml (●).

L. C. Paoletti, et al. Infect Immun. 2001 November;69(11):6696-6701.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk